Factors Associated with Intention to Utilize Cervical Cancer Prevention Strategies among Pregnant Women Attending Antenatal Clinics in Ibadan, Nigeria


  •   O. B. Ani

  •   Professor Chris Aimakhu

  •   I. O. Morhason-Bello


Cervical cancer is the second commonest cancer among women in Nigeria, with one-third of all cases occurring during the reproductive period. However, different barriers, including the unaffordability of vaccines and ineffective screening programs, delay preventive measures. Hence, the need to adequately tackle those barriers to improve uptake. Using an interviewer-administered questionnaire, the descriptive cross-sectional study design was adopted to gather data from 344 pregnant women attending antenatal clinics in three hospitals in Ibadan. Data collected were entered into the Statistical Package for Social Sciences, version 20.0. Frequency distribution tables, mean, figures, and multinomial logistics regression were used to summarize and present the data. Most Pregnant women, 34.3%, were aged between 25-29 years, with 35.8.% of them having poor knowledge of HPV, while 61.1% had poor knowledge of cervical cancer. Also, 43.3% of the participants had never heard of HPV. In addition, 47.7% of respondents stated that distance to a health facility could hinder their utilization of cervical cancer prevention strategies. The multinomial logistic regression showed a significant association between awareness of HPV Vaccination and plan for HPV vaccination aOR 0.32 CI (0.14 – 0.76), and plan for cervical cancer screening aOR 0.24 CI (0.11 – 0.53) respectively. It is crucial to correct the negative perception and attitude towards cervical cancer and its preventive measures to help to increase its adoption.

Keywords: Cervical cancer, factors, intention, preventive measures


WHO. World Cancer Report. [Internet] 2014 [cited 2015 November 6] Available from: http://www.who.int/mediacentre/ factsheets/fs099/en/

WHO. World Health Organization: Human papillomavirus vaccines. [Internet] 2017 [cited 2018 July 11] Available from: http://www.apps.who.int/iris/bitstream/handle/10665/255353/WER 9219.pdf?sequence=1.

GLOBOCAN. Global Cancer Incidence, Mortality and Prevalence Fact sheets on Cervical Cancer. [Internet] 2020 Available from: https://gco.iarc.fr/today/fact-sheets-cancers

WHO. World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2013.

Centers for Disease Control and Prevention (CDC). Human Papillomavirus (HPV) Vaccination: What Everyone Should Know. [Internet] 2017 [cited 2017 October 17] Available from: https://www.cdc.gov/vaccines/vpd/hpv/public/index.html.

WHO. World Health Organization: Human Papilloma Virus (HPV) and Cervical Cancer. [Internet] 2020 Available from: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.

UNFPA. African Women’s Development Fund, Integrated Africa cancer factsheet Focusing on cervical cancer, girls and women health, HIV and maternal health. [Internet] 2014 Available from: https://www.who.int/pmnch/media/events/2014/africa_cancer_factsheet.pdf

FMOH. Federal Ministry of Health. National strategic action plan (NSAP) for prevention and control of non-communicable diseases in Ethiopia 2014–2016. [Internet] 2014 Available from: https://www.iccp portal.org/system/files/plans/ETH_B3_National%20Strategic%20Action%20Plan%20%28NSAP%29%20for%20Prevention%20and%20Control%20of%20Non-Communicable%20Diseases%20-%20Final.pdf

FMOH. Federal Ministry of Health, Nigeria (FMOH). Nigeria National cancer control plan 2018 –2022. [Internet] 2018 Available from: https://www.iccpportal.org/system/files/plans/NCCP_Final%20%5B1%5D.pdf

Jacobs IA, Chang CK, Salti GI. Coexistence of pregnancy and cancer. The American Surgeon. 2004; 70(11): 1025.

Traen K, Svane D, Kryger-Baggesen N, Bertelsen K, Mogensen O. Stage Ib cervical cancer during pregnancy: planned delay in treatment--case report. European Journal of Gynaecological Oncology. 2006; 27(6): 615-7.

Kaur H, Schmidt-Grimminger D, Remmenga SW, Chen B, Islam KM. Does human papillomavirus affect pregnancy outcomes? An analysis of hospital data 2012–2014. Int J Women’s Health Wellness. 2015; 1.

Nwankwo KC, Aniebue UU, Aguwa EN, Anarado AN, Agunwah E. Knowledge attitudes and practices of cervical cancer screening among urban and rural Nigerian women: a call for education and mass screening. European Journal of Cancer Care. 2011; 20(3): 362-7.

Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA: A Cancer Journal for Clinicians. 2012; 62(3): 147-72.

Watts L, Joseph N, Velazquez A, Gonzalez M, Munro E, Muzikansky A, et al. Understanding barriers to cervical cancer screening among Hispanic women. American Journal of Obstetrics and Gynecology. 2009; 201(2): 199 e1–199 e8.

Gebru Z, Gerbaba M, Dirar A. Utilization of cervical carcinoma screening service and associated factors among currently married women in Arba Minch town, southern Ethiopia. J Women’s Health Care. 2016; 5(297): 2167-0420.

Gregg JL. An unanticipated source of hope: stigma and cervical cancer in Brazil. Medical Anthropology Quarterly. 2011; 25(1): 70-84.

Paz-Soldán VA, Bayer AM, Nussbaum L, Cabrera L. Structural barriers to screening for and treatment of cervical cancer in Peru. Reproductive Health Matters. 2012; 20(40): 49-58.

Chidyaonga-Maseko F, Chirwa ML, Muula AS. Underutilization of cervical cancer prevention services in low-and-middle-income countries: a review of contributing factors. Pan African Medical Journal. 2015; 21(1).

Feyi-Waboso PA, Kamanu C, Aluka C. Awareness and risk factors for cervical cancer among women in Aba, south-eastern Nigeria. Tropical Journal of Obstetrics and Gynaecology. 2005; 22: 25-6.

Ndikom CM, Ofi BA. Awareness, perception, and factors affecting utilization of cervical cancer screening services among women in Ibadan, Nigeria: a qualitative study. Reproductive Health. 2012; 9(1): 1-8.

Udigwe GO. Knowledge, attitude, and practice of cervical cancer screening (pap smear) among female nurses in Nnewi South Eastern Nigeria. Nigerian Journal of Clinical Practice. 2006; 9(1): 40-3.

Gharoro EP, Ikeanyi EN. An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution. International Journal of Gynecologic Cancer. 2006; 16(3).

Nygård JF, Nygård M, Skare GB, Thoresen SO. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia. Acta Cytologica. 2006; 50(3): 295-302.

Thomas VN, Saleem T, Abraham R. Barriers to effective uptake of cancer screening among Black and minority ethnic groups. International journal of palliative nursing. 2005; 11(11): 562-71.

Pegu B, Dhiman N, Chaturvedi J, Sharma SK. Nurse’s knowledge and attitude regarding cervical cancer screening at a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2017; 6: 907-10.

Mugassa AM, Frumence G. Factors influencing the uptake of cervical cancer screening services in Tanzania: A health system perspective from national and district levels. Nursing Open. 2020; 7(1): 345-54.

Donadiki EM, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, Lopez de Andres A, Jimenez-Trujillo I, et al. Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece. Human Vaccines & Immunotherapeutics. 2013; 9(2): 300-5.

Jelastopulu E, Fafliora E, Plota A, Babalis V, Bartsokas C, Poulas K, et al. Knowledge, behaviours and attitudes regarding HPV infection and its prevention in female students in West Greece. Age. 2016; 21: 2-06.

Chiang VC, Wong HT, Yeung PC, Choi YK, Fok MS, Mak OI, et al. Attitude, acceptability and knowledge of HPV vaccination among local university students in Hong Kong. International Journal of Environmental Research and Public Health. 2016; 13(5): 486.

Bendik MK, Mayo RM, Parker VG. Knowledge, perceptions, and motivations related to HPV vaccination among college women. Journal of Cancer Education. 2011; 26(3): 459-64.

Feng S, Xu X, Jin Y, Yao X. Women’s knowledge of human papillomavirus (HPV) and their attitudes toward HPV vaccine: Preparing for HPV vaccination in China. Asia Pacific Journal of Public Health. 2012.

Fernandez ME, Le YC, Fernandez-Espada N, Calo, WA, Savas LS, Velez C, et al. Knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination among Puerto Rican mothers and daughters, 2010: A qualitative study. Prev. Chronic Dis. 2014; 11: E212.

Gerald EI, Ogwuche CH. Educational level, sex and church affiliation on health seeking behaviour among parishioners in Makurdi metropolis of Benue state. Journal of Educational Policy and Entrepreneurial Research. 2014; 1(2): 311-6.

Lee M, Park EC, Chang HS, Kwon JA, Yoo KB, Kim TH. Socioeconomic disparity in cervical cancer screening among Korean women: 1998–2010. BMC Public Health. 2013; 13(1): 1-8.

Lyimo FS, Beran TN. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications. BMC Public Health. 2012; 12(1): 22.

Nene B, Jayant K, Arrossi S, Shastri S, Budukh A, Hingmire S, et al. Determinants of women’s participation in cervical cancer screening trial, Maharashtra, India. Bulletin of the World Health Organization. 2007; 85: 264-72.

Gichangi, P., Estambale, B., Bwayo, J., 2003. Knowledge and practice about cervical cancer and Pap smear among patients at Kenyatta National Hospital, Nairobi. Int J Gynecol Canc. 13: 827–833.


Download data is not yet available.


How to Cite
Ani, O. B., Aimakhu, C. O., & Morhason-Bello, I. O. (2022). Factors Associated with Intention to Utilize Cervical Cancer Prevention Strategies among Pregnant Women Attending Antenatal Clinics in Ibadan, Nigeria. European Journal of Medical and Health Sciences, 4(1), 72–79. https://doi.org/10.24018/ejmed.2022.4.1.1210